The FDA has set a May 1 target action date for uniQure’s Huntington’s disease gene therapy candidate ifezuntirgene inilparvovec, after accepting the company’s Biologics License Application (BLA) under ...

Study findings reframe pulmonary hypertension as a multi-organ inflammatory disorder and point to potential diagnostic, prognostic targets.

The FDA has delayed a decision on Agios Pharmaceuticals’ supplemental New Drug Application seeking additional approval for mitapivat in sickle cell disease until next year.

Genomics launches Sentira, an Anthropic Claude-powered AI platform designed to accelerate single-cell data analysis.

Shares of gene editing therapy companies mostly surged this past week on two growth catalysts: Data readouts at the European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress, and the ...

Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-cell multimodal dataset combining single-cell ...

Artiva Biotherapeutics said it will eviscerate its workforce 94% and evaluate strategic options after two patients treated ...

Single-cell atlas gives researchers a baseline for exploring how injury, aging, drugs, or other changes affect cells across ...

Plans include investing in AI-driven experimental execution, extending its automation capabilities, and expanding into new markets.

Patient safety, expanding access to gene therapy, and progress towards an HIV vaccine were prominent themes among the early ...

The data showed 26 percent of neurons in the prenatal cortex had copy number variants, but this decreased to about 6 percent after birth.

TrUDI three-photon microscopy captures neural activity deep in the mouse brain at single-cell resolution without removing ...